Addressing drug shortages requires the industry to embrace innovative advanced manufacturing processes underpinned by ...

Bruce Leuchter, CEO, Neurvati, discusses the indispensable role of patient advocates—particularly in rare and serious disease drug development—in shaping trial design, site selection, and regulatory ...